Raising Awareness of
Women’s Heart Recovery

Watch Jessica’s Story

Raising Awareness of
Women’s Heart Recovery

Watch Laura's Story

The Impella heart pump provides a treatment option for women suffering from cardiogenic shock caused by peripartum and postpartum cardiomyopathy (PPCM).

What is Peripartum Cardiomyopathy?

PPCM occurs during pregnancy or after childbirth and is a leading cause of pregnancy-related deaths in the United States2. The disease is often difficult to diagnose, with a mortality rate of 10%, mainly driven by cardiogenic shock. This condition can lead to poor outcomes for the infant and carries a high risk of relapse in subsequent pregnancies3, 4, 5. Historic hospital protocols prioritized the life of the mother during the cardiogenic shock episode. With Impella support, patients can have minimally invasive therapy and avoid invasive surgeries and severe drug therapy.

Cardiovascular Disease

Cardiovascular Disease

is the number one killer of women and causes 35% of deaths in American women over the age of 201.

Read More

Peripartum Cardiomyopathy

occurs during pregnancy or after childbirth and is a leading cause of pregnancy-related deaths in the United States.

Read More

Myocarditis

A form of cardiomyopathy, is a rare
inflammation of the heart muscle
triggered by infection, autoimmune
diseases, or other causes.

Read More

Impella® heart pumps temporarily assist the pumping function of the heart to ensure blood is delivered to the rest of the body, allowing it to rest and potentially recover its native function.

  1. Heart Disease Statistics. CardioSmart, American College of Cardiology: https://www.cardiosmart.org/Heart-Basics/CVD-Stats.
  2. Centers for Disease Control and Prevention, Trends in Pregnancy-Related Deaths: https://www.cdc.gov/reproductivehealth/maternalinfanthealth/pmss.html.
  3. Kolte D, Khera S, et al. Temporal Trends in Incidence and Outcomes of Peripartum Cardiomyopathy in the United States: A Nationwide Population-Based Study. J Am Heart Assoc. 2014 Jun 4;3(3):e001056. doi: 10.1161/JAHA.114.001056.
  4. Bhattacharyya, A., Sukhdeep, SB, et al. Peripartum Cardiomyopathy: A Review. Tex Heart Inst J. 2012; 39(1): 8—16.
  5. Sliwa K, Hilfiker-Kleiner D, et al. Current State of Knowledge on Aetiology, Diagnosis, Management, and Therapy of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Eur J Heart Fail. 2010;12(8): 767—78.
  6. Grosseto D, Santarelli A, Carigi S, Baldazzi F, Franco N, Santoro D et al. Incidence of Spontaneous Coronary Artery Dissection in All Comers Patients Referred for Acute Coronary Syndrome [abstract 194] Eur Heart J: Acute Cardiovasc Care. 2012;1(1 Suppl):61.
  7. Hayes SN. Spontaneous Coronary Artery Dissection (SCAD): New Insights into This Not-So-Rare Condition. Texas Heart Institute Journal. 2014;41(3):295-298. doi:10.14503/THIJ-14-4089.